WallStreetZenWallStreetZen

NASDAQ: CME
Cme Group Inc Stock Forecast, Predictions & Price Target

Analyst price target for CME

Based on 8 analysts offering 12 month price targets for Cme Group Inc.
Min Forecast
$161.00-8.87%
Avg Forecast
$206.88+17.1%
Max Forecast
$250.00+41.51%

Should I buy or sell CME stock?

Based on 8 analysts offering ratings for Cme Group Inc.
Hold
Strong Buy
1 analysts 12.5%
Buy
3 analysts 37.5%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
1 analysts 12.5%

Be the first to know when Wall Street analysts revise their CME stock forecasts and price targets.

CME stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JP Morgan
Bottom 43%
43
HoldMaintains$194.00+9.81%2023-04-19
Oppenheimer
Bottom 15%
15
BuyMaintains$221.00+25.09%2023-04-12
Morgan Stanley
Bottom 29%
29
HoldMaintains$208.00+17.73%2023-04-11
Rosenblatt
Top 34%
67
Strong SellReiterates$161.00-8.87%2023-04-05
Morgan Stanley
Bottom 13%
13
HoldMaintains$201.00+13.77%2023-02-13
Credit Suisse
Top 22%
79
BuyMaintains$207.00+17.17%2023-02-09
Oppenheimer
Top 9%
92
BuyMaintains$213.00+20.56%2023-01-19
Piper Sandler
Bottom 11%
11
Strong BuyMaintains$250.00+41.51%2022-12-19

1 of 1

Forecast return on equity

Is CME forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
72.91%

Forecast return on assets

Is CME forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CME earnings growth forecast

How is CME forecast to perform vs Financial Data & Stock Exchanges companies and vs the US market?
Company
4.65%
Industry
22.43%
Market
26.1%
CME's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CME's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CME's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CME revenue growth forecast

How is CME forecast to perform vs Financial Data & Stock Exchanges companies and vs the US market?
Company
4.91%
Industry
4.28%
Market
8.34%
CME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CME vs Financial Datum & Stock Exchange Stocks

TickerPricePrice TargetUp/downsideConsensus
CME$176.67$206.88+17.10%Hold
ICE$105.16$128.88+22.55%Buy
MCO$313.00$330.30+5.53%Buy
MSCI$475.83$578.33+21.54%Strong Buy
NDAQ$54.22$66.00+21.73%Buy

Cme Group Stock Forecast FAQ

Is Cme Group Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: CME) stock is to Hold CME stock.

Out of 8 analysts, 1 (12.5%) are recommending CME as a Strong Buy, 3 (37.5%) are recommending CME as a Buy, 3 (37.5%) are recommending CME as a Hold, 0 (0%) are recommending CME as a Sell, and 1 (12.5%) are recommending CME as a Strong Sell.

If you're new to stock investing, here's how to buy Cme Group stock.

What is CME's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CME) forecast ROE is N/A, which is considered weak.

What is CME's Price Target?

According to 8 Wall Street analysts that have issued a 1 year CME price target, the average CME price target is $206.88, with the highest CME stock price forecast at $250.00 and the lowest CME stock price forecast at $161.00.

On average, Wall Street analysts predict that Cme Group's share price could reach $206.88 by Apr 19, 2024. The average Cme Group stock price prediction forecasts a potential upside of 17.1% from the current CME share price of $176.67.

What is CME's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CME) forecast ROA is N/A, which is lower than the forecast US Financial Data & Stock Exchanges industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.